UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immune Checkpoint Inhibition in Colorectal Cancer: Microsatellite Instability and Beyond

Targeted oncology, 2020-02, Vol.15 (1), p.11-24

2020

Volltextzugriff (PDF)

Nanoliposomal irinotecan in advanced biliary tract cancers

The lancet. Gastroenterology & hepatology, 2024-08, Vol.9 (8), p.683-684

2024

Volltextzugriff (PDF)

Epidemiology of microsatellite instability across solid neoplasms

Bulletin du cancer, 2019-02, Vol.106 (2), p.114

2019

Volltextzugriff (PDF)

Molecular Targets for the Treatment of Metastatic Colorectal Cancer

Cancers, 2020-08, Vol.12 (9), p.2350

2020

Volltextzugriff (PDF)

Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency

Cancers, 2021-03, Vol.13 (5), p.1149

2021

Volltextzugriff (PDF)

Investigation of a Mycobacterium fortuitum catheter-related bloodstream infection in an oncology unit

Infection control and hospital epidemiology, 2023-08, Vol.44 (8), p.1342-1344

2023

Volltextzugriff (PDF)

Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer

Cancers, 2022-01, Vol.14 (2), p.406

2022

Volltextzugriff (PDF)

Immunotherapy and patients treated for cancer with microsatellite instability

Bulletin du cancer, 2017-01, Vol.104 (1), p.42-51

2017

Volltextzugriff (PDF)

Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer

JNCI : Journal of the National Cancer Institute, 2021-02, Vol.113 (2), p.208-211

2021

Volltextzugriff (PDF)

Épidémiologie des tumeurs MSI : fréquence des tumeurs MSI en fonction de la localisation du cancer et de son stade

Bulletin du cancer, 2019-02, Vol.106, p.114-118

2019

Volltextzugriff (PDF)

Épidémiologie des tumeurs MSI : fréquence des tumeurs MSI en fonction de la localisation du cancer et de son stade

Bulletin du cancer, 2019-02, Vol.106 (2), p.114-118

2019

Volltextzugriff (PDF)

Letter to the Editor from Colle et al

Journal for immunotherapy of cancer, 2021-06, Vol.9 (6), p.e002997

2021

Volltextzugriff (PDF)

Pseudoprogression in patients treated with immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer

European journal of cancer (1990), 2021-02, Vol.144, p.9-16

2021

Volltextzugriff (PDF)

Efficacy and tolerability of immune checkpoint inhibitors in elderly patients with MSI/dMMR gastrointestinal cancers and impact of toxicities on efficacy: The immunoMSI cohort

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.795-795

2023

Volltextzugriff (PDF)

Parameters associated with outcomes in pretreated MSI/dMMR metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICI): Subgroup analysis of a prospective cohort

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3580-3580

2021

Volltextzugriff (PDF)

BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors

The oncologist (Dayton, Ohio), 2023-09, Vol.28 (9), p.771-779

2023

Volltextzugriff (PDF)

Pathological complete response of a metastatic MisMatch Repair deficient/MicroSatellite Instable colon cancer after immunotherapy: A case report

Annales de pathologie, 2022-03, Vol.42 (2), p.172-176

2022

Volltextzugriff (PDF)

Prevalence of NTRK1/3 fusions in mismatch repair-deficient (dMMR)/microsatellite instable (MSI) tumors of patients with metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e15537-e15537

2021

Volltextzugriff (PDF)

Réponse histologique complète d’un cancer colique métastatique de phénotype MisMatch Repair déficient/MicroSatellite Instable après immunothérapie : à propos d’un cas

Annales de pathologie, 2022-03, Vol.42 (2), p.172-176

2022

Volltextzugriff (PDF)

Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer

European journal of cancer (1990), 2022-09, Vol.172, p.171-181

2022

Volltextzugriff (PDF)

Impact of Lynch syndrome, BRAF V600E , and RAS mutations on outcomes in MSI/dMMR metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICI): Analysis of combined international cohorts

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.171-171

2023

Volltextzugriff (PDF)

RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors

The oncologist (Dayton, Ohio), 2023-09, Vol.28 (9), p.771

2023

Volltextzugriff (PDF)

Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers

Journal for immunotherapy of cancer, 2022-02, Vol.10 (2), p.e004001

2022

Volltextzugriff (PDF)

Adrenal gland as a sanctuary site for immunotherapy in patients with microsatellite instability-high metastatic colorectal cancer

Journal for immunotherapy of cancer, 2021-02, Vol.9 (2), p.e001903

2021

Volltextzugriff (PDF)

Biliary tract cancers in the age of targeted therapies

Hepato-gastro, 2023-04, Vol.30 (S2), p.4-9

2023

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(36)

Sprache

Englisch
(32)
Französisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immune Checkpoint Inhibition in Colorectal Cancer: Microsatellite Instability and Beyond

Nanoliposomal irinotecan in advanced biliary tract cancers

Epidemiology of microsatellite instability across solid neoplasms

Molecular Targets for the Treatment of Metastatic Colorectal Cancer

Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency

Investigation of a Mycobacterium fortuitum catheter-related bloodstream infection in an oncology unit

Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer

Immunotherapy and patients treated for cancer with microsatellite instability

Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer

Épidémiologie des tumeurs MSI : fréquence des tumeurs MSI en fonction de la localisation du cancer et de son stade

Épidémiologie des tumeurs MSI : fréquence des tumeurs MSI en fonction de la localisation du cancer et de son stade

Letter to the Editor from Colle et al

Pseudoprogression in patients treated with immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer

Efficacy and tolerability of immune checkpoint inhibitors in elderly patients with MSI/dMMR gastrointestinal cancers and impact of toxicities on efficacy: The immunoMSI cohort

Parameters associated with outcomes in pretreated MSI/dMMR metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICI): Subgroup analysis of a prospective cohort

BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors

Pathological complete response of a metastatic MisMatch Repair deficient/MicroSatellite Instable colon cancer after immunotherapy: A case report

Prevalence of NTRK1/3 fusions in mismatch repair-deficient (dMMR)/microsatellite instable (MSI) tumors of patients with metastatic colorectal cancer (mCRC)

Réponse histologique complète d’un cancer colique métastatique de phénotype MisMatch Repair déficient/MicroSatellite Instable après immunothérapie : à propos d’un cas

Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer

Impact of Lynch syndrome, BRAF V600E , and RAS mutations on outcomes in MSI/dMMR metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICI): Analysis of combined international cohorts

RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors

Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers

Adrenal gland as a sanctuary site for immunotherapy in patients with microsatellite instability-high metastatic colorectal cancer

Biliary tract cancers in the age of targeted therapies

Suchergebnisse filtern